The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9802907 B1

PDF
Full Text
Expired
Date of Patent:
Oct. 31, 2017

Filed:

Nov. 24, 2013
Applicant:

Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd., Zhenjiang, CN;

Inventors:

Dongfang Shi, Zhenjiang, CN;

Changjin Fu, Zhenjiang, CN;

Jie Wu, Zhenjiang, CN;

Jun Liu, Zhenjiang, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 293/06 (2006.01); C07D 421/10 (2006.01); A61K 31/381 (2006.01); A61K 33/04 (2006.01); A61K 31/41 (2006.01); A61K 31/4365 (2006.01); A61K 31/4439 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); C07D 421/12 (2006.01); C07D 495/04 (2006.01);
U.S. Cl.
CPC ...
C07D 293/06 (2013.01); A61K 31/41 (2013.01); A61K 31/4365 (2013.01); A61K 31/4439 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); C07D 421/10 (2013.01); C07D 421/12 (2013.01); C07D 495/04 (2013.01);
Abstract

A 2-aryl selenazole compound and a pharmaceutical composition are disclosed, wherein the 2-aryl selenazole compound is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The 2-aryl selenazole compound has the activity of inhibiting xanthine oxidase. The compound or a pharmaceutically acceptable salt thereof can be applied in terms of preparing a drug used for prevention or treatment of hyperuricemia, gout, diabetic nephropathy, an inflammatory disease or a neurological disease.


Find Patent Forward Citations

Loading…